Commonwealth Equity Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-24,946
Closed -$2.89M 4072
2023
Q3
$2.89M Sell
24,946
-675
-3% -$72.5K 0.01% 1360
2023
Q2
$2.63M Sell
25,621
-4,488
-15% -$473K 0.01% 1445
2023
Q1
$3.29K Sell
30,109
-1,544
-5% -$171K 0.01% 1239
2022
Q4
$3.6M Sell
31,653
-39
-0.1% -$3.24K 0.01% 1141
2022
Q3
$1.96M Sell
31,692
-4,536
-13% -$317K 0.01% 1427
2022
Q2
$2.89M Buy
36,228
+715
+2% +$67.7K 0.01% 1201
2022
Q1
$3.74M Sell
35,513
-649
-2% -$63.2K 0.01% 1118
2021
Q4
$3.9M Buy
36,162
+6,549
+22% +$714K 0.01% 1062
2021
Q3
$3.24M Buy
29,613
+3,884
+15% +$403K 0.01% 1133
2021
Q2
$2.41M Buy
25,729
+3,641
+16% +$335K 0.01% 1306
2021
Q1
$2.03M Buy
22,088
+9,241
+72% +$780K 0.01% 1316
2020
Q4
$939K Buy
12,847
+4,449
+53% +$331K ﹤0.01% 1693
2020
Q3
$652K Buy
8,398
+137
+2% +$9.43K ﹤0.01% 1781
2020
Q2
$459K Sell
8,261
-186
-2% -$7.96K ﹤0.01% 1946
2020
Q1
$250K Buy
+8,447
New +$286K ﹤0.01% 2202
2018
Q3
Sell
-10,702
Closed -$177K 2896
2018
Q2
$177K Sell
10,702
-4,125
-28% -$62.9K ﹤0.01% 2499
2018
Q1
$210K Sell
14,827
-186
-1% -$2.75K ﹤0.01% 2367
2017
Q4
$219K Sell
15,013
-1,000
-6% -$14K ﹤0.01% 2307
2017
Q3
$203K Buy
16,013
+1,016
+7% +$12.9K ﹤0.01% 2279
2017
Q2
$178K Sell
14,997
-3,556
-19% -$44.2K ﹤0.01% 2272
2017
Q1
$274K Buy
18,553
+2,830
+18% +$45.8K ﹤0.01% 1916
2016
Q4
$254K Buy
+15,723
New +$285K ﹤0.01% 1888
2016
Q1
Sell
-17,075
Closed -$370K 2286
2015
Q4
$370K Buy
+17,075
New +$332K ﹤0.01% 1459
2015
Q3
Sell
-9,000
Closed -$313K 2264
2015
Q2
$313K Buy
+9,000
New +$275K ﹤0.01% 1610

Other funds holding HZNP